ConductScience.org, home

Paper8405033

Pharmacokinetic study and effects on growth hormone secretion in healthy volunteers of the new somatostatin analogue BIM 23014.

Kuhn JM and 6 others. Eur J Clin Pharmacol, 1993. Cited by 26 papers, by iCite.

Cite this record

ConductScience Library. Pharmacokinetic study and effects on growth hormone secretion in healthy volunteers of the new somatostatin analogue BIM 23014. Papers, record 8405033. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8405033

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pharmacokinetic study and effects on growth hormone secretion in healthy volunteers of the new somatostatin analogue BIM 23014.
PubMed
Journal
Eur J Clin Pharmacol
PubMed
Year
1993
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
26
iCite
Relative citation ratio, by iCite
0.96
iCite
Revised in PubMed
2019-08-13
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kuhn JMJ M
2Basin CC
3Mollard MM
4de Rougé BB
5Baudoin CC
6Obach RR
7Tolis GG

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Growth HormoneMajor topic
Growth Hormone-Releasing HormoneMajor topic
Peptides, CyclicMajor topic
SomatostatinMajor topic
Adult
Humans
Injections, Intravenous
Injections, Subcutaneous
Male

Source PubMed

Download CSV of topics

References30

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12451917Demonstration of insulin-like growth factor (IGF-I and -II) receptors and binding protein in human breast cancer cell lines.Biochem Biophys Res Commun1988https://conductscience.org/library/papers/2451917PubMed
22858917Two types of somatostatin receptors differentiated by cyclic somatostatin analogs.Science1985https://conductscience.org/library/papers/2858917PubMed
32055192Growth of human breast cancer cell lines is inhibited by the somatostatin analog BIM23014.Endocrinology1991https://conductscience.org/library/papers/2055192PubMed
42878079Design and synthesis of conformationally constrained somatostatin analogues with high potency and specificity for mu opioid receptors.J Med Chem1986https://conductscience.org/library/papers/2878079PubMed
56315757Growth hormone binding to cultured human breast cancer cells.J Clin Endocrinol Metab1984https://conductscience.org/library/papers/6315757PubMed
62886933Differential binding of somatostatin agonists to somatostatin receptors in brain and adenohypophysis.Neuroendocrinology1987https://conductscience.org/library/papers/2886933PubMed
72839551Insulin-like growth factor-I can mediate autocrine proliferation of human small cell lung cancer cell lines in vitro.J Clin Invest1988https://conductscience.org/library/papers/2839551PubMed
83312244Growth regulation of human breast carcinoma occurs through regulated growth factor secretion.J Cell Biochem1987https://conductscience.org/library/papers/3312244PubMed
92880660Direct inhibitory effects of somatostatin (analogues) on the growth of human breast cancer cells.Cancer Res1987https://conductscience.org/library/papers/2880660PubMed
102893361Mu-opiate binding and morphine antagonism by octapeptide analogs of somatostatin.Peptides1987https://conductscience.org/library/papers/2893361PubMed
112872570Cyclic somatostatin octapeptide analogues with high affinity and selectivity toward mu opioid receptors.Life Sci1986https://conductscience.org/library/papers/2872570PubMed
122884564Response of thyrotropin-secreting pituitary adenomas to a long-acting somatostatin analogue.N Engl J Med1987https://conductscience.org/library/papers/2884564PubMed
132569933Somatostatin and somatostatin analogues in oncology.Cancer Treat Rev1989https://conductscience.org/library/papers/2569933PubMed
148095269Pharmacokinetics and efficacy of a long-acting formulation of the new somatostatin analog BIM 23014 in patients with acromegaly.J Clin Endocrinol Metab1993https://conductscience.org/library/papers/8095269PubMed
152900205Effect of a long-acting somatostatin derivative SMS 201-995 (sandostatin) on glucose homeostasis in type I diabetes mellitus.Horm Res1988https://conductscience.org/library/papers/2900205PubMed
162885701Inhibition of rat prostate tumor growth by an octapeptide analog of somatostatin.Life Sci1987https://conductscience.org/library/papers/2885701PubMed
172869278Prolonged treatment of Zollinger-Ellison syndrome by long-acting somatostatin.Lancet1986https://conductscience.org/library/papers/2869278PubMed
186129852Physiological roles of somatocrinin and somatostatin in the regulation of growth hormone secretion.Biochem Biophys Res Commun1982https://conductscience.org/library/papers/6129852PubMed
192869845Interaction between growth hormone releasing factor (GRF) and somatostatin analogue (SMS 201-995) in normal subjects.Clin Endocrinol (Oxf)1985https://conductscience.org/library/papers/2869845PubMed
202891721Differential effects of somatostatin (SRIH) and a SRIH analog, SMS 201-995, on the secretion of growth hormone and thyroid-stimulating hormone in man.J Clin Endocrinol Metab1988https://conductscience.org/library/papers/2891721PubMed

See all 30 referencesDownload CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.

PMIDTitleJournalYearIn PapersSource
35128405Cyclic peptide drugs approved in the last two decades (2001-2021).RSC Chem Biol2022https://conductscience.org/library/papers/35128405PubMed
35000098Paltusotine, a novel oral once-daily nonpeptide SST2 receptor agonist, suppresses GH and IGF-1 in healthy volunteers.Pituitary2022https://conductscience.org/library/papers/35000098PubMed
32557353Somatostatin receptor expression and patients' response to targeted medical treatment in pituitary tumors: evidences and controversies.J Endocrinol Invest2020https://conductscience.org/library/papers/32557353PubMed
32121432Somatostatin Analogs in Clinical Practice: a Review.Int J Mol Sci2020https://conductscience.org/library/papers/32121432PubMed
31412614Biological and Biochemical Basis of the Differential Efficacy of First and Second Generation Somatostatin Receptor Ligands in Neuroendocrine Neoplasms.Int J Mol Sci2019https://conductscience.org/library/papers/31412614PubMed
16984213Pharmacokinetic profile of the somatostatin analogue lanreotide in individuals with chronic hepatic insufficiency.Clin Pharmacokinet2006https://conductscience.org/library/papers/16984213PubMed
10435849Long-term treatment of acromegaly with the somatostatin analogue SR-lanreotide.J Endocrinol Invest1999https://conductscience.org/library/papers/10435849PubMed
7826822Pharmacokinetic and pharmacodynamic properties of a long-acting formulation of the new somatostatin analogue, lanreotide, in normal healthy volunteers.Br J Clin Pharmacol1994https://conductscience.org/library/papers/7826822PubMed

Download CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
BCL2L1110018PubTator's text mininghttps://conductscience.org/library/genes/10018NCBI Gene
GGH8836PubTator's text mininghttps://conductscience.org/library/genes/8836NCBI Gene
GH12688PubTator's text mininghttps://conductscience.org/library/genes/2688NCBI Gene
GHRH2691PubTator's text mininghttps://conductscience.org/library/genes/2691NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8405033

GET https://conductscience.org/api/papers/v1/8405033/references?page=2